· 10 min read
Introducing HexemBio: A New Approach to Blood Stem Cell Rejuvenation
Our lead program targets improvement of bone marrow transplant outcomes in blood cancer patients. But HSC aging connects to a broad range of disease mechanisms across immunity, neurodegeneration, organ decline, and infection susceptibility. If you could extend the number of healthy, active years people live, not just their lifespan, it would dramatically improve how they age.
Read the story
